EndoTool IV Physician User Guide Content Expert:

Slides:



Advertisements
Similar presentations
Managing Sick Days and Hospital Stays Mike Heile MD Orlando, CWD July, 2011.
Advertisements

Using the Insulin Subcutaneous Order & Blood Glucose Record – Adult
Adult Standardised Subcutaneous Insulin Prescribing Chart
Susan Alexander, DNP, CNS, CRNP, BC- ADM College of Nursing University of Alabama in Huntsville Clinical Affiliation: Outpatient Diabetes Self-Management.
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Canadian Diabetes Association Clinical Practice Guidelines Hyperglycemic Emergencies in Adults Chapter 15 Jeannette Goguen, Jeremy Gilbert.
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
SMH DKA PROTOCOL Physician Information. Insulin Drip protocol for DKA  Purpose: Quick/Safe management of the patient in DKA  Method: Evidence based.
DIABETES Cameron VanTassell MS,RD,BC-ADM. HbA1c Definition-a stable glycoprotein formed when glucose binds to hemoglobin A in the blood in a concentration.
Introducing The SHINE Trial (Stroke Hyperglycemia Insulin Network Effort) An Overview for Clinical Nurses NIH-NINDS U01 NSO69498.
Hyperglycaemia Diabetes Outreach (August 2011). 2 Hyperglycaemia Learning objectives >Can state what hyperglycaemia is >Is aware of the short term and.
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Diabetes.. Definition. The term of diabetes describes several syndromes of abnormal carbohydrates metabolism that are characterized by hyperglycemia.
Management Tools and CGM Kathryn Moe, RN CDE Medtronic Diabetes.
Perioperative Diabetes Management Dr. Ken Locke March 2007.
4-07 CHANGE IS GOOD: THE BASAL BOLUS INSULIN CONCEPT Management of Hyperglycemia in the Adult Hospitalized Patient: Admission to Discharge TEAM MEMBERS:
Chapter 24 Chapter 24 Exercise Management.  Diabetes is a chronic metabolic disease characterized by an absolute or relative deficiency of insulin that.
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
4-06 CHANGE IS GOOD: THE BASAL BOLUS INSULIN CONCEPT Management of Hyperglycemia in the Adult Hospitalized Patient TEAM MEMBERS: Physicians: Maryann Emanuele,
Diabetes Technology Update
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.
L.M. Fisk, A.J. Le Compte, G.M. Shaw, S. Penning, T. Desaive, J.G. Chase Pilot Trial of STAR in Medical ICU INTRODUCTION Background: Accurate glycemic.
Basal and Meal Time Insulin Case Study
MANAGEMENT OF THE HOSPITALIZED TYPE I DIABETIC PATIENT Riverside Methodist Hospital January 23, 2014 Rundsarah Tahboub, MD.
Inpatient Glycemic Management
Diabetes Update Division of Endocrinology Department of Medicine Wayne State University Medical School Detroit, Michigan Part 3 of 3.
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Adult Medical-Surgical Nursing Endocrine Module: Acute Complications of Diabetes Mellitus.
Improving Patient Outcomes GLYCEMIC CONTROL IN PERI-OPERATIVE PATIENTS UTILIZING INSULIN INFUSION PROTOCOLS.
EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Dr Stanley Ngare.  Pharmacology of Types of insulin available  Various routes of delivery & factors that affect absorption  Patient and provider barriers.
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
2. Basal Insulin, Meal, and Standard -Screen will change and display units based on weight -Glargine rounds to nearest 5 units for dose greater than 20.
1 Module 5 Pharmacologic Management of Hospital Hyperglycemia: Insulin Management Part 2 Diabetes Special Interest Group Georgia Hospital Association.
Multidisciplinary Diabetes Team Activities in a 196 Bed Community Hospital Robin Southwood, Pharm.D, CDE and Beth Melvin, RD, MS, CDE.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA.
Adult SQ Insulin Advisor Be on the look-out for VUMC’s new subcutaneous adult insulin advisor Orderable in WIZ/HEO. Physician Driven, unlike the Insulin.
Achieving Glycemic Control in the Hospital Setting
DIABETIC KETOACIDOSIS Emergency pediatric – PICU division H. Adam Malik Hospital – Medical School University of Sumatera Utara 1.
Medical Management of Diabetes During Ramadan Jennifer Hamilton, MD August, 2007 CE Rajab, 1428 AH.
Insulin order sets – only way to order sustained insulin. Separate versions for 1 st time order and revision.
Special Situations In The Management Of In-Patient Hyperglycemia
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocol Cases.
Strategies to Reduce Hypoglycemia Presented by: Hennie Garza, M.S., R.Ph., C.D.E, Director of Pharmacy Utilization and Outcomes Senior Care Centers
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
New Subcutaneous Insulin Protocol for Type 2 Diabetics
Glycemia Treatment Strategies Used In ACCORD
Pharmacy Protocol for Insulin Dosing in the Hospitalized Patient
Management of diabetes mellitus in hospitalized patients
DKA TREATMENT GUIDELINES.
Diabetes Health Status Report
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Endocrine Emergencies & Management
Diabetes and Stroke.
Monitoring in Type 2 Diabetes
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
SCREENING AND MANAGEMENT OF ASYMPTOMATIC NEWBORNS
Clinician Materials For Your Reference
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Paul Szczybor PA-C DFAAPA Lifebridge Critical Care
Managing Hypoglycemia & Hyperglycemia
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.
PowerPoint 16:9 Screen Ratio Template *
Celia Levesque MSN, RN, CNS-BC, NP-C, CDE, BC-ADM
Therapy Guide July 2019.
NEW INSULIN ORDER SETS (NON-ICU AREAS)
Presentation transcript:

EndoTool IV 1.8.4 Physician User Guide Content Expert: Karen Pritts, MS, RD, CDE; Director, Center for Diabetes & Endocrinology New: August 14, 2017 CME education assigned to all Physicians

Glucommander Replacement The Glucommander insulin drip software has been replaced with EndoTool IV by Monarch Medical. EndoTool IV software system has been reviewed against the medical standards for IV insulin drip protocols; Portland, Yale, and Atlanta protocols. The start date for EndoTool IV was August 16, 2017. CME opportunity is available for all physicians under MVH Link & Applications-MVH Website-Education.

What is EndoTool IV? EndoTool IV is a software program that calculates the initial insulin drip dose taking into account patient specifics: Current body weight Age Type of diabetes Renal function Patient’s insulin sensitivity Steroids EndoTool IV will pull information from Meditech EMR for calculation purposes. The use of insulin drips & EndoTool IV is currently for patients in either ED, ICU, or CCU.

MVH Goals to Treat Hyperglycemia To decrease the rates of hyperglycemia in our patients with or without diabetes, standards of medical care indicate the use of insulin drips for; Steroids Pre-op and Post-op Acute illness with hyperglycemia Our hyperglycemia rates for Fiscal 2017 Q4: 1216 episodes with a 15% attempted treatment rate for patients with diabetes. Our goal is to decrease the number of hyperglycemia episodes with successful treatment.

How Does EndoTool IV Work? EndoTool IV uses 3 modes of therapy to correct elevated BGs due to either DKA, HNS, or Hyperglycemia. DKA Mode calculates insulin drip rates until BG goal range (BG 140-180 mg/dl) is met. It will then prompt change to the ordered Hyperglycemia goal range. HNS Mode calculates insulin drip rates until BG goal range (BG 180-220 mg/dl) is met. It will then prompt change to the ordered Hyperglycemia goal range. Hyperglycemia Mode calculates the insulin drip rates until the ordered BG goal range is met: BGs 110-150 mg/dl or BGs 90-120 mg/dl for CVA or MI. The Hyperglycemia Mode can be used for patients w/o DKA or HNS, but need IV insulin to manage high BGs (i.e. steroids, post-op, undiagnosed diabetes, steroids w/o hx of diabetes …). Dr Tal also included a BG goal range of 90-120 mg/dl for patients experiencing a CVA or MI.

Types of diabetes used in calculations. EndoTool defines diabetes type as: 0 = Non diabetic; patient has no history or undiagnosed. 1 = Type 1 DM (absolute insulin deficiency at dx). 2 = Type 2 DM (insulin resistance & decreased insulin production). Gestational = gestational diabetes dx during pregnancy. Unknown = patient not able to communicate and medical hx for diabetes is unknown.

EndoTool IV Setup Parameters for EndoTool calculations were recommended by Dr Tal, the Medical Director of the Center for Diabetes & Endo. The MD will need to complete the MVH EndoTool IV Insulin Drip orders. Select mode of therapy Hyperglycemia (BG goal range 110-150 mg/dl). Hyperglycemia with CVA or MI (BG goal range 90-120 mg/dl). DKA (BG goal range 140-180 mg/dl). HNS ( BG goal range 180-220 mg/dl). Select the Blood Glucose Goal Range once DKA or HNS resolved. BGs goal: 110-150 mg/ld BGs goal: 90-120 mg/dl (CVA or MI) Select type & rate of continuous IV Dextrose with NSS. D5 ½ NSS at 125 ml/hr. Other fluids equivalent to 6.25 gm CHO/hr: ______ at _______ml/hr. Nursing will enter the parameters ordered into EndoTool IV.

Steroids The EndoTool IV will adjust IV insulin dose calculations based on steroid use. Due to the degree of insulin resistance created by steroids, the insulin drip could be used for patients with hyperglycemia without a history of diabetes.

Hypoglycemia Prevention & Treatment EndoTool IV is setup to prevent hypoglycemia. EREI (Estimated Residual and Extracellular Insulin) is used by EndoTool IV to calculate the Supplemental Carbohydrate treatment. EndoTool IV will prompt use of Supplemental Carbohydrate when the BG result is 70-80 mg/dl. Oral treatment: Dex4 glucose drink or glucose gel IV treatment: D10W specific dose To treat hypoglycemia (BG <70 mg/dl), EndoTool IV will recommend a treatment using D50. EndoTool IV has a hypoglycemia treatment goal of a blood glucose 130 mg/dl.

IV Spreadsheet CDE Special Panel

Transitioning off Insulin Drip Once blood glucose goals are met, EndoTool IV will prompt the nurse to begin transition off the insulin drip. The physician will complete the MVH EndoTool IV Insulin Drip Transition Orders. Initial subcutaneous Lantus insulin dose to be give 2 hours prior to d/c drip. Bedside blood glucose monitoring. Insulin correction scale and type of insulin. Order daily basal insulin dose of Lantus. Hypoglycemia Protocol.

EndoTool IV Operation Questions Our IT staff (x1157) will help with technical issues (log-in/password, network or hardware). EndoTool IV Monarch Medical is also available 24 hours/7days for clinical & application questions (877-349-4582).